Chinese drugmakers with big ambitions struggle to recruit staff for global expansion

Chinese drugmakers with global ambitions (including Jiangsu Hengrui Pharmaceuticals and CanSino Biologics) are finding it difficult to recruit internationally experienced staff needed to develop and commercialize medicines overseas. Executives link the hiring challenge to slower/uncertain execution of international growth plans, creating a cautious outlook for near-term global commercialization progress.

Analysis

Chinese drugmakers with global ambitions (including Jiangsu Hengrui Pharmaceuticals and CanSino Biologics) are finding it difficult to recruit internationally experienced staff needed to develop and commercialize medicines overseas. Executives link the hiring challenge to slower/uncertain execution of international growth plans, creating a cautious outlook for near-term global commercialization progress.